As of November 6, 2026, Lifecore Biomedical, Inc. \de\ is a publicly traded company (Nasdaq: LFCR). The largest holder reporting an active stake on Schedule 13D is Legion Partners Asset Management, LLC, at 17.3%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include BlackRock (5.4%) (Schedule 13D/A, September 28, 2026).
Is this your company?
About to sign with, pay or invest in Lifecore Biomedical, Inc. \de\? See the free Snapshot first.
Free to see. No signup.
Is Lifecore Biomedical, Inc. \de\ a real, registered company?
- Lifecore Biomedical, Inc. files with the SEC under CIK 1005286 (its SEC filings).
- Its shares are listed under the ticker LFCR on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Chaska, Minnesota, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under LIFECORE BIOMEDICAL, INC. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Wynnefield Partners Small Cap Value, L.P. I (filed 2026-09-29).
Who are Lifecore Biomedical, Inc. \de\'s owners and officers?
Lifecore Biomedical, Inc. \de\: incorporated in Delaware; business address in Chaska, Minnesota; industry Pharmaceutical Preparations (Schedule 13D/A, 2026-09-29).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-09-29 | Wynnefield Partners Small Cap Value, L.P. I | 14.3% |
| Schedule 13D/A, 2026-09-28 | Legion Partners Asset Management, LLC | 17.3% |
| Schedule 13G, 2026-07-29 | Blackrock, Inc. | 5.4% |
| Schedule 13D/A, 2026-07-02 | Legion Partners Asset Management, LLC | 17.1% |
| Schedule 13D/A, 2026-07-02 | 22nw Fund, LP | 6.74% |
| Schedule 13G/A, 2026-04-27 | Blackrock, Inc. | 4.98% |
| Schedule 13G, 2026-01-21 | Blackrock, Inc. | 5.1% |
| Schedule 13G/A, 2025-10-17 | Blackrock, Inc. | 4.9% |
| Schedule 13G, 2025-07-17 | Blackrock, Inc. | 5% |
Questions about who owns Lifecore Biomedical, Inc. \de\
Who owns Lifecore Biomedical, Inc. \de\?
On this page, 4 holders' latest ownership filings report 5% or more of Lifecore Biomedical, Inc. \de\: Legion Partners Asset Management, LLC (17.3%, Schedule 13D/A, filed 2026-09-28), Wynnefield Partners Small Cap Value, L.P. I (14.3%, Schedule 13D/A, filed 2026-09-29), 22nw Fund, LP (6.74%, Schedule 13D/A, filed 2026-07-02) and Blackrock, Inc. (5.4%, Schedule 13G, filed 2026-07-29).
Who are the largest shareholders of Lifecore Biomedical, Inc. \de\?
By the share each holder's latest filing reports, the largest holders of Lifecore Biomedical, Inc. \de\ on this page are Legion Partners Asset Management, LLC (17.3%), Wynnefield Partners Small Cap Value, L.P. I (14.3%) and 22nw Fund, LP (6.74%).
When did Legion Partners Asset Management, LLC buy into Lifecore Biomedical, Inc. \de\?
The filings give report dates, not purchase dates. The earliest filing from Legion Partners Asset Management, LLC on this page is the Schedule 13D/A, filed 2026-07-02, reporting 17.1%; its latest, Schedule 13D/A filed 2026-09-28, reports 17.3%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Lifecore Biomedical, Inc. \de\?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lifecore Biomedical, Inc. \de\: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lifecore Biomedical, Inc. \de\ covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Lifecore Biomedical, Inc. \de\ shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Wynnefield Capital Management LLC, a 10% owner: 4,703,216 shares (12.4% of shares outstanding), 2,095,783 held directly and 2,607,433 indirectly, on a joint filing (Form 4, 2024-10-07).
- Wynnefield Partners Small Cap Value LP I, a 10% owner: 4,703,216 shares (12.4% of shares outstanding), 2,095,783 held directly and 2,607,433 indirectly, on a joint filing (Form 4, 2024-10-07).
- Wynnefield Capital, Inc. Profit Sharing Plan, a 10% owner: 4,703,216 shares (12.4% of shares outstanding), 2,095,783 held directly and 2,607,433 indirectly, on a joint filing (Form 4, 2024-10-07).
- Wynnefield Partners Small Cap Value LP, a 10% owner: 4,703,216 shares (12.4% of shares outstanding), 2,095,783 held directly and 2,607,433 indirectly, on a joint filing (Form 4, 2024-10-07).
- Wynnefield Capital Inc., a 10% owner: 4,703,216 shares (12.4% of shares outstanding), 2,095,783 held directly and 2,607,433 indirectly, on a joint filing (Form 4, 2024-10-07).
Shares outstanding: 37,905,846 as of 2026-10-28, from the company's latest SEC cover page.
How much has Lifecore Biomedical, Inc. \de\ raised?
Latest IPO step: Lifecore Biomedical, Inc. \de\ filed to go public (S-1, 2024-10-10).
IPO filings: S-1, 2024-10-10; ticker LFCR on Nasdaq Global Select Market.
Keep reading
More on Lifecore Biomedical, Inc. \de\ and the records around it.
Lifecore Biomedical, Inc. \de\ elsewhere on the record
- 5%+ stake filings Sep 2026
Companies that share a holder
- Legion Partners, L.P. I also filed stake reports on 2 other companies: NN INC (Aug 2026), Clear Channel Outdoor Holdings, Inc. (Jun 2026)
- 22NW Fund, LP also filed stake reports on 7 other companies: PhenixFIN Corp (May 2026), FARMER BROTHERS CO (May 2026), FOSTER L B CO (Apr 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/lifecore-biomedical